GlassScriptPhysician profile
Godefroy Sullyvan Chery
NPI 1043742430
$21,479.94
in general payments reported to CMS, 2019-2025
14 companies · $6,320 in 2025
The $6,320 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.38 · 2022: $883 · 2023: $6,769 · 2024: $7,497 · 2025: $6,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $7,543 · Grant: $2,000 · Education: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,546.54 |
| Food and Beverage | $7,542.50 |
| Grant | $2,000.00 |
| Education | $496.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,088.80 | 2023-2025 | Micra, Affera Mapping System, Sphere-9 |
| Boston Scientific Corporation | $4,943.63 | 2020-2025 | Emblem Mri S-Icd, Versacross Access Solution, Watchman Access System |
| Biotronik INC. | $2,379.34 | 2022-2025 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $2,273.77 | 2024-2025 | Carto 3, Qdot Micro |
| Medical Device Business Services, INC. | $1,561.74 | 2024 | Carto 3 |
| Abbott Laboratories | $833.86 | 2025 | Ensite, Gallant, Assurity |
| Janssen Pharmaceuticals, INC | $156.38 | 2024 | Xarelto |
| Becton, Dickinson and Company | $61.72 | 2025 | Hemosphere |
| Cardiva Medical, INC. | $56.22 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Bridgebio Pharma, INC. | $37.68 | 2025 | Attruby |
| Stryker Corporation | $25.69 | 2025 | Flowtriever |
| Atricure, INC. | $25.50 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Chiesi USA, INC. | $20.69 | 2025 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $14.92 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Godefroy Chery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.